JAB JAB Acquisition Corp I

Executive Summary

JAB Acquisition Corp I filed Amendment No. 2 to its S-1 registration statement for a SPAC IPO, dated June 5, 2026. The company is offering 15,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share, one warrant (exercise price $11.50), and one right to receive 1/4 of a Class A ordinary share upon a business combination. The sponsor is purchasing 260,000 private units simultaneously. Gross proceeds of $150M ($172.5M with over-allotment) will be placed in trust, with a 12-month completion window extendable by up to two three-month periods. This is a procedural amendment with no material changes from prior filings — no target has been selected.

Key Financial Metrics

Actionable Insight

Key Facts

• Offering 15,000,000 units at $10.00/unit, each unit = 1 Class A share + 1 warrant ($11.50 strike) + 1 right (1/4 share upon business combination)
• Underwriters have 45-day option for up to 2,250,000 additional units
• Sponsor JAB Acquisition Sponsor I, LLC purchasing 260,000 private units at $10.00/unit ($2.6M total)
• Gross proceeds of $150M ($172.5M with over-allotment) deposited in trust account
• 12 months to complete initial business combination, extendable by up to two three-month periods with $0.10/share deposit each
• Sponsor holds 9,857,143 founder shares purchased for $25,000 ($0.002/share); up to 1,285,714 subject to forfeiture if over-allotment not exercised
• Management targets enterprise value of $200M or greater; focus on technology, healthcare, and logistics
• No target selected and no substantive discussions initiated with any target

Financial Impact

IPO gross proceeds of $150,000,000 (or $172,500,000 with over-allotment) to be held in trust. Sponsor investing $2,600,000 in private units. Estimated offering expenses of $1,655,000 leave ~$945,000 in working capital outside trust.

Risk Factors

• No operating history and no revenue — entirely dependent on finding and completing a business combination within 12-18 months
• Significant dilution risk: sponsor's founder shares purchased at $0.002/share vs. $10.00 public offering price, creating misaligned incentives
• If no business combination completed, trust proceeds returned to public shareholders but warrants and rights expire worthless
• Competition from other SPACs and acquisition vehicles for attractive targets

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

US Market Status